Last updated on October 2018

A Study in Male and Female Subjects With Androgenetic Alopecia Treated With ATI-50002 Topical Solution


Brief description of study

Open label study to assess safety, tolerability, and efficacy of ATI-50002 in male and female subjects with androgenetic alopecia.

Detailed Study Description

This is an open-label study designed to evaluate the safety and efficacy of ATI-50002 Topical Solution in male and female subjects with androgenetic alopecia.

Clinical Study Identifier: NCT03495817

Contact Investigators or Research Sites near you

Start Over

Judy Schnyder

Aclaris Investigational Site
Denver, CO United States

Judy Schnyder

Aclaris Investigational Site
Portland, OR United States

Judy Schnyder

Aclaris Investigational Site
Austin, TX United States